Table 1 Pathologic and clinical information of 10x Genomics sequencing samples.
Patient ID | Tissue site | Sample ID | Sex | Age | Pathology | TNM stage |
|---|---|---|---|---|---|---|
D1 | Primary site | chrRCC_P | Male | 54 | (Right Kidney) Chromophobe cell carcinoma with iliac bone metastases | Satge III |
Para-tumor site | chrRCC_N | |||||
Metastatic tumor site | chrRCC_B | |||||
D2 | Primary site | pRCC3 | Male | 61 | (Right kidney) Papillary renal cell carcinoma, Type 1.Both ureter and vascular end (−) | Satge I |
D3 | Primary site | sarRCC_P | Male | 39 | (Right kidney) the tumor cells are distinctly heterogeneous, considering a renal cell carcinoma with sarcomatoid differentiation | Satge IV |
Para-tumor site | sarRCC_N | |||||
Metastatic tumor site | sarRCC_L | |||||
D4 | Primary site | cdRCC_P | Female | 27 | (Right kidney) Collecting duct carcinoma with hilar and retroperitoneal lymph node metastasis and spinal metastasis | Satge IV |
Metastatic tumor site | cdRCC_L | |||||
Metastatic tumor site | cdRCC_B | |||||
D5 | Primary site | pRCC1 | Unknown | 70 | Papillary renal cell carcinoma | Stage I |
Para-tumor site | pRCC1N | |||||
Primary site | pRCC2 | |||||
Para-tumor site | pRCC2N |
